Medicine & Health

School of Medicine researchers have found that the delta variant of the virus that causes COVID-19 is largely unable to evade antibodies elicited by vaccination. The findings help explain why vaccinated people have been at low risk of getting seriously ill with COVID-19.

Noor Riaz, MD, a pediatric hospitalist, has been named the 2021-23 Carol B. and Jerome T. Loeb Teaching Fellow at the School of Medicine.

Findings from the Department of Psychological & Brain Sciences in Arts & Sciences and the School of Medicine suggest cannabis use disorder should be added to the list of COVID-19 risk factors.

The School of Medicine’s Robyn Klein, MD, PhD, has received an $8.7 million grant from the National Institutes of Health (NIH) to investigate how viruses may cause diseases of “pathological forgetting.”

Washington University’s Jonathan Silva and Jeanne Nerbonne led a team that found that two drugs sometimes prescribed to treat arrhythmias affect heart atria and ventricles differently depending on the molecular composition of the sodium channels expressed.

Joe Rowles, a postdoctoral research associate working with Gary Patti in chemistry in Arts & Sciences, won a Molecular Oncology Training Grant to support his participation in the Siteman Cancer Center’s Cancer Biology Pathway Program.

Sumanth D. Prabhu, MD, an internationally recognized expert in how immunity and inflammation contribute to heart failure, has been named director of the Cardiovascular Division in the Department of Medicine at Washington University School of Medicine.

With an $8.8 million grant from the National Institutes of Health (NIH), researchers at Washington University School of Medicine will study how an individual’s risks of cardiometabolic diseases are influenced by the interaction of specific genes with demographic and lifestyle factors.

This year’s W.M. Keck Fellowships in Molecular Medicine have been awarded to three postdoctoral researchers at Washington University. The fellowships are funded with a gift from the W.M. Keck Foundation.

Funded by a $33 million grant, a new study led by School of Medicine and University of Michigan researchers will compare intravenous propofol to inhaled anesthetic drugs to determine which of the common anesthetic drugs offers better patient recovery experiences and improved clinical outcomes.